Pacira Pharmaceuticals (PCRX) PT Lowered to $80 at Barclays
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $23.24 --0%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 23
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 23
Join SI Premium – FREE
Barclays analyst Balaji Prasad lowered the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $80.00 (from $90.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
- National Australia Bank Ltd. (NAB:AU) (NABZY) PT Lowered to AUD39.90 at JPMorgan
- Corteva Inc. (CTVA) PT Lowered to $85 at UBS Amid High Expectations
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
